Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Denmark Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20073
20082
20096
20102
20112
20122
20133
20142
20152
20173
20181
20191
20202
20211
20221
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting9
Unknown status5
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Pfizer4
AstraZeneca3
Sanofi3
Bristol-Myers Squibb2
Celgene2
Janssen Research & Development, LLC2
Amgen1
Aragon Pharmaceuticals, Inc.1
Bavarian Nordic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms41
Neoplasm Metastasis5
Neoplasms3
Bulbo-Spinal Atrophy, X-Linked1
Osteoporosis1
Urinary Incontinence1
Urinary Incontinence, Stress1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.